Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

SAM-e for the Treatment of Depression in Patients With Parkinson's Disease
SAM-e Treatment of Depression in Parkinson's Disease
Status: Archived
New York University
mi
from
New York, NY
SAM-e for the Treatment of Depression in Patients With Parkinson's Disease
SAM-e Treatment of Depression in Parkinson's Disease
Status: Archived
Updated: 1/1/1970
New York University
mi
from
New York, NY
Function of Catecholamines in the Brain During Depression
Neural Correlates of Depressive Symptoms and Reward Related Mechanisms Following AMPT Depletion in Remitted Depressed Patients Off Treatment and Healthy Controls
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Function of Catecholamines in the Brain During Depression
Neural Correlates of Depressive Symptoms and Reward Related Mechanisms Following AMPT Depletion in Remitted Depressed Patients Off Treatment and Healthy Controls
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Family Care Specialists at White Memorial Medical Center
mi
from
Los Angeles, CA
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Updated: 1/1/1970
Family Care Specialists at White Memorial Medical Center
mi
from
Los Angeles, CA
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Northeast Valley Health Corporation-San Fernando Valley High School
mi
from
San Fernando, CA
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Updated: 1/1/1970
Northeast Valley Health Corporation-San Fernando Valley High School
mi
from
San Fernando, CA
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Dayton Children's
mi
from
Dayton, OH
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Updated: 1/1/1970
Dayton Children's
mi
from
Dayton, OH
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Updated: 1/1/1970
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Capital Medical Group
mi
from
Chevy Chase, MD
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Updated: 1/1/1970
Capital Medical Group
mi
from
Chevy Chase, MD
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Kaiser Mid-Atlantic
mi
from
Kensington, MD
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Updated: 1/1/1970
Kaiser Mid-Atlantic
mi
from
Kensington, MD
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Kaiser Mid-Atlantic-Camp Springs
mi
from
Temple Hills, MD
Teen Depression Awareness Project (TDAP)
Teen Depression Awareness Project
Status: Archived
Updated: 1/1/1970
Kaiser Mid-Atlantic-Camp Springs
mi
from
Temple Hills, MD
Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis
Fish Oil as an Adjunct Therapy for Depression in Multiple Sclerosis
Status: Archived
Oregon Health and Science University
mi
from
Portland, OR
Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis
Fish Oil as an Adjunct Therapy for Depression in Multiple Sclerosis
Status: Archived
Updated: 1/1/1970
Oregon Health and Science University
mi
from
Portland, OR
Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive Disorder
Culturally Congruent Care for Hispanic Outpatients With Major Depressive Disorder (MDD)
Status: Archived
New York State Psychiatric Insitute
mi
from
New York, NY
Effectiveness of Culturally Based Congruent Care in Treating Hispanics With Major Depressive Disorder
Culturally Congruent Care for Hispanic Outpatients With Major Depressive Disorder (MDD)
Status: Archived
Updated: 1/1/1970
New York State Psychiatric Insitute
mi
from
New York, NY
Effectiveness of Interpersonal Psychotherapy in Treating Pregnant Women With Depression
Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Sites
Status: Archived
New York State Psychiatric Insitute
mi
from
New York, NY
Effectiveness of Interpersonal Psychotherapy in Treating Pregnant Women With Depression
Antepartum Study on Use of Interpersonal Psychotherapy at 3 New York City Sites
Status: Archived
Updated: 1/1/1970
New York State Psychiatric Insitute
mi
from
New York, NY
Bipolar II Depression: Lithium, SSRI, or the Combination
Comparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression
Status: Archived
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Bipolar II Depression: Lithium, SSRI, or the Combination
Comparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression
Status: Archived
Updated: 1/1/1970
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Bipolar II Depression: Lithium, SSRI, or the Combination
Comparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression
Status: Archived
Stanford University - Bipolar Research Program
mi
from
Palo Alto, CA
Bipolar II Depression: Lithium, SSRI, or the Combination
Comparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression
Status: Archived
Updated: 1/1/1970
Stanford University - Bipolar Research Program
mi
from
Palo Alto, CA
Bipolar II Depression: Lithium, SSRI, or the Combination
Comparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression
Status: Archived
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Bipolar II Depression: Lithium, SSRI, or the Combination
Comparing the Safety and Effectiveness of a Mood Stabilizing Medication, an Antidepressant Medication, and a Combination of Both Medications to Treat Symptoms of Bipolar Type II Depression
Status: Archived
Updated: 1/1/1970
The Lindner Clinical Trial Center
mi
from
Cincinnati, OH
Treatment of Depression Following Multiple Brain Tests
Medication Treatment Following Neuropsychologic, Dichotic and f-MRI Tests in Depressed Outpatients With Repeat f-MRI Following Treatment
Status: Archived
Depression Research Unit
mi
from
Philadelphia, PA
Treatment of Depression Following Multiple Brain Tests
Medication Treatment Following Neuropsychologic, Dichotic and f-MRI Tests in Depressed Outpatients With Repeat f-MRI Following Treatment
Status: Archived
Updated: 1/1/1970
Depression Research Unit
mi
from
Philadelphia, PA
Exercise to Treat Depression in Individuals With Coronary Heart Disease
Understanding the Prognostic Benefits of Exercise and Anti-depressant Therapy (UPBEAT)
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
Exercise to Treat Depression in Individuals With Coronary Heart Disease
Understanding the Prognostic Benefits of Exercise and Anti-depressant Therapy (UPBEAT)
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Interpersonal Psychotherapy for Depression in People With Heart Failure
Interpersonal Psychotherapy for Depression in Patients With Heart Failure
Status: Archived
University of Iowa
mi
from
Iowa City, IA
Interpersonal Psychotherapy for Depression in People With Heart Failure
Interpersonal Psychotherapy for Depression in Patients With Heart Failure
Status: Archived
Updated: 1/1/1970
University of Iowa
mi
from
Iowa City, IA
Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression
Omega-3 Fatty Acids for Treatment of Major Depression: Differential Effects of EPA and DHA, and Associated Biochemical and Immune Parameters
Status: Archived
The Depression Clinical and Research Program, Massachusetts General Hospital
mi
from
Boston, MA
Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression
Omega-3 Fatty Acids for Treatment of Major Depression: Differential Effects of EPA and DHA, and Associated Biochemical and Immune Parameters
Status: Archived
Updated: 1/1/1970
The Depression Clinical and Research Program, Massachusetts General Hospital
mi
from
Boston, MA
Supportive Therapy Versus Problem Solving Therapy in Treating Depressed, Cognitively Impaired Older Adults
A Treatment for Depressed, Cognitively Impaired Elders
Status: Archived
Cornell Institute of Geriatric Psychiatry
mi
from
White Plains, NY
Supportive Therapy Versus Problem Solving Therapy in Treating Depressed, Cognitively Impaired Older Adults
A Treatment for Depressed, Cognitively Impaired Elders
Status: Archived
Updated: 1/1/1970
Cornell Institute of Geriatric Psychiatry
mi
from
White Plains, NY
Escitalopram in Treating Depression in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Symptom Management Trial in Cancer Survivors
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Escitalopram in Treating Depression in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Symptom Management Trial in Cancer Survivors
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Feasibility of Depression Care Management by E-Mail
Pilot Trial of Depression Care Management by Electronic Secure Messaging
Status: Archived
Group Health Cooperative Center for Health Studies
mi
from
Seattle, WA
Feasibility of Depression Care Management by E-Mail
Pilot Trial of Depression Care Management by Electronic Secure Messaging
Status: Archived
Updated: 1/1/1970
Group Health Cooperative Center for Health Studies
mi
from
Seattle, WA
Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)
An Investigation of the Antidepressant Efficacy of a Selective, High, Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder
Status: Archived
Clinical Research Facility
mi
from
Baltimore, MD
Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)
An Investigation of the Antidepressant Efficacy of a Selective, High, Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Baltimore, MD
Psychiatric Genotype/Phenotype Project Repository
Psychiatric Genotype/Phenotype Project
Status: Archived
Vanderbilt University Medical Center
mi
from
Nashville, TN
Psychiatric Genotype/Phenotype Project Repository
Psychiatric Genotype/Phenotype Project
Status: Archived
Updated: 1/1/1970
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Clinical Trial Facility
mi
from
Newington, CT
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Newington, CT
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Clinical Trial Facility
mi
from
Metairie, LA
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Metairie, LA
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Clinical Trial Facility
mi
from
Jackson, MS
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Jackson, MS
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Clinical Trial Facility
mi
from
Albany, NY
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Albany, NY
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Clinical Trial Facility
mi
from
Philadelphia, PA
A Study of RO4917523 in Patients With Treatment Resistant Depression
An Exploratory Fixed Dose Randomized Double Blind Parallel-group Placebo-controlled Study of the Safety and of the Therapeutic Effects of Ro 4917523 in Patients With Treatment- Resistant Depression
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Philadelphia, PA
Effectiveness of a Web-based Prevention Program for Postpartum Depression
Using the Internet for English/Spanish Randomized Trials for Postpartum Depression
Status: Archived
University of California, San Francisco
mi
from
San Francisco, CA
Effectiveness of a Web-based Prevention Program for Postpartum Depression
Using the Internet for English/Spanish Randomized Trials for Postpartum Depression
Status: Archived
Updated: 1/1/1970
University of California, San Francisco
mi
from
San Francisco, CA
Serum Markers as a Bioassay for Unipolar Depression
Validation of Serum Markers as a Bioassay for Unipolar Depression
Status: Archived
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Serum Markers as a Bioassay for Unipolar Depression
Validation of Serum Markers as a Bioassay for Unipolar Depression
Status: Archived
Updated: 1/1/1970
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Brain Effects of Escitalopram and Citalopram Using fMRI
A Comparison of the CNS Effects of Equivalent Doses of Escitalopram and Racemic Citalopram Using BOLD fMRI
Status: Archived
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Brain Effects of Escitalopram and Citalopram Using fMRI
A Comparison of the CNS Effects of Equivalent Doses of Escitalopram and Racemic Citalopram Using BOLD fMRI
Status: Archived
Updated: 1/1/1970
Caritas St. Elizabeth's Medical Center
mi
from
Boston, MA
Use of Conversation and Acoustic Signals in Measuring Depression Severity
Use of Conversation and Acoustic Signals in Measuring Depression Severity
Status: Archived
Boston Med Center
mi
from
Boston, MA
Use of Conversation and Acoustic Signals in Measuring Depression Severity
Use of Conversation and Acoustic Signals in Measuring Depression Severity
Status: Archived
Updated: 1/1/1970
Boston Med Center
mi
from
Boston, MA
Women's Depression Treatment Study
Effectiveness of IPT Adapted for Depressed Women With Trauma Histories in a Community Mental Health Center
Status: Archived
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
Women's Depression Treatment Study
Effectiveness of IPT Adapted for Depressed Women With Trauma Histories in a Community Mental Health Center
Status: Archived
Updated: 1/1/1970
Strong Memorial Hospital (University of Rochester School of Medicine)
mi
from
Rochester, NY
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Dana-Farber / Harvard Cancer Center
mi
from
Boston, MA
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Memorial Hospital of Rhode Island
mi
from
Pawtucket, RI
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Miami, FL
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Miami, FL
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Maine Center for Cancer Medicine and Blood Disorders - Scarborough
mi
from
Scarborough, ME
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Alexandria, LA
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Alexandria, LA
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Hartford Hospital- The Institute of Living
mi
from
Hartford, CT
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Omaha, NE
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Omaha, NE
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Bridgewater, NJ
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Bridgewater, NJ
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Brooklyn, NY
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Brooklyn, NY
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Cincinnati, OH
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Cincinnati, OH
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Muskogee, OK
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Muskogee, OK
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Chattanooga, TN
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Chattanooga, TN
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Fort Worth, TX
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Worth, TX
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
American Fork, UT
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
American Fork, UT
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Clinical Research Facility
mi
from
Seattle, WA
A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
Study to Access the Efficacy and Safety of Olanzapine and Fluoxetine Combination Versus Placebo in Patients Ages 10-17 in the Treatment of Major Depressive Episodes Associated With Bipolar Disorder
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Seattle, WA